Rhythm Pharmaceuticals (RYTM) Interest & Investment Income (2016 - 2026)
Rhythm Pharmaceuticals (RYTM) posted quarterly Interest & Investment Income of $3.6 million for Q1 2026, down 2.34% year-over-year from $3.6 million in Q1 2025, and down 13.0% quarter-over-quarter from $4.1 million in Q4 2025.
Powered by 
Analysis
Rhythm Pharmaceuticals (RYTM) Interest & Investment Income (2016 - 2026) Analysis & Trends
Rhythm Pharmaceuticals (RYTM) has reported Interest & Investment Income for 11 consecutive years, with $3.6 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Interest & Investment Income fell 2.34% year-over-year to $3.6 million; the TTM figure through Mar 2026 stood at $15.2 million (down 0.63% YoY), while the FY2025 annual figure was $15.3 million, up 3.96% from the prior year.
- Interest & Investment Income fell to $3.6 million in Q1 2026 per RYTM's latest filing, from $4.1 million in the prior quarter.
- Across five years, Interest & Investment Income topped out at $4.3 million in Q3 2025 and bottomed at $160000.0 in Q1 2022.
- Historically, Interest & Investment Income has averaged $3.1 million across 5 years, with a median of $3.5 million in 2023.
- Annual changes were most pronounced in 2022 — Interest & Investment Income surged 2169.4% — and 2025, when it dropped 20.87%.
- Rhythm Pharmaceuticals' Interest & Investment Income stood at $3.0 million in 2022, then climbed by 25.58% to $3.8 million in 2023, then fell by 7.96% to $3.5 million in 2024, then increased by 16.22% to $4.1 million in 2025, then decreased by 13.0% to $3.6 million in 2026.
- Business Quant data shows RYTM's Interest & Investment Income at $3.6 million in Q1 2026, $4.1 million in Q4 2025, and $4.3 million in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.31 Bn | 131.46 Bn | 2.84 Bn | 120.60 Mn |
| 2 | Regeneron Pharmaceuticals | 85.65 Bn | 77.66 Bn | 3.93 Bn | -48.00 Mn |
| 3 | Argenx Se | 63.46 Bn | 58.27 Bn | 1.37 Bn | 48.00 Mn |
| 4 | Moderna | 57.94 Bn | 52.80 Bn | 52.00 Mn | 67.00 Mn |
| 5 | Revolution Medicines | 44.05 Bn | 44.05 Bn | - | 35.58 Mn |
| 6 | BeOne Medicines | 39.96 Bn | 34.86 Bn | 1.53 Bn | 27.90 Mn |
| 7 | Alnylam Pharmaceuticals | 35.16 Bn | 31.85 Bn | 992.69 Mn | 28.14 Mn |
| 8 | Royalty Pharma | 28.44 Bn | 27.60 Bn | - | 5.13 Mn |
| 9 | Insmed | 27.32 Bn | 26.16 Bn | 358.27 Mn | 10.98 Mn |
| 10 | Rhythm Pharmaceuticals | 7.04 Bn | 6.71 Bn | 62.32 Mn | 3.22 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.22 Mn |
| Mar 31, 2026 | 3.55 Mn |
| Dec 31, 2025 | 4.09 Mn |
| Sep 30, 2025 | 4.33 Mn |
| Jun 30, 2025 | 3.24 Mn |
| Mar 31, 2025 | 3.64 Mn |
| Dec 31, 2024 | 3.52 Mn |
| Sep 30, 2024 | 4.05 Mn |
| Jun 30, 2024 | 4.10 Mn |
| Mar 31, 2024 | 3.05 Mn |
| Dec 31, 2023 | 3.82 Mn |
| Sep 30, 2023 | 3.47 Mn |
| Jun 30, 2023 | 3.22 Mn |
| Mar 31, 2023 | 3.44 Mn |
| Dec 31, 2022 | 3.04 Mn |
| Sep 30, 2022 | 920,000.00 |
| Jun 30, 2022 | 274,000.00 |
| Mar 31, 2022 | 160,000.00 |
| Dec 31, 2021 | 134,000.00 |
| Sep 30, 2021 | 138,000.00 |